Prognostic Factors on the Positivity for Metastases of the Axillary Lymph Nodes from Primary Breast Cancer

1. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181-187.10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-HSearch in Google Scholar

2. Giuliano A. E., Kirgan D. M., Guenther J. M., Morton D. L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Annals of Surgery. 1994;220(3):391-401.10.1097/00000658-199409000-00015Search in Google Scholar

3. Maunsell E, Brisson J & Deshenes L. Arm problems and psychological distress after surgery for breast cancer. Canadian Journal of Surgery 1993 Aug, 36(4) 315-20.Search in Google Scholar

4. Fisher B, Jeong JH, Anderson S, et al. Twentyfive- year follow-up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N Engl J Med.2002;347(8):567-575.10.1056/NEJMoa020128Search in Google Scholar

5. Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancer of the breast. N Engl J Med.1981;305(1):6-11.10.1056/NEJM198107023050102Search in Google Scholar

6. Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA & Lavin PT 1996 The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Archives of Surgery 131 301-308.10.1001/archsurg.1996.01430150079015Search in Google Scholar

7. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer. 1997;79:1918-22.10.1002/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.0.CO;2-YSearch in Google Scholar

8. Tan YY, Wu CT, Fan YG, et al. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer. Breast J. 2005;11:338-43.10.1111/j.1075-122X.2005.00043.xSearch in Google Scholar

9. Ravdin PM, De Laurentiis M, Vendely T, Clark GM. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst. 1994;86:1771-75.10.1093/jnci/86.23.1771Search in Google Scholar

10. Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003;10:248-54.10.1245/ASO.2003.05.020Search in Google Scholar

11. Patani NR, Dwek MV, Douek M.Predictors of axillary lymph node metastasis in breast cancer: a systematic review.Eur J Surg Oncol. 2007 May;33(4):409-19.10.1016/j.ejso.2006.09.003Search in Google Scholar

12. Ahmed M, Purushotham AD, Douek M. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review.Lancet Oncol. 2014 Jul;15(8):e351-62.10.1016/S1470-2045(13)70590-4Search in Google Scholar

13. W. Byon, E. Kim, J. Kwon, BJ.Song, C. Park. FDG-PET, MRI and USG in the assessment of axillary lymph node metastases in breast cancer- The Breast 24S1 (2015) S67.10.1016/S0960-9776(15)70165-7Search in Google Scholar

14. Hwang SO1, Lee SW, Kim HJ, Kim WW, Park HY, Jung JH. The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and (18) F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer.J Breast Cancer. 2013 Sep;16(3):315-21.10.4048/jbc.2013.16.3.315380072824155761Search in Google Scholar

15. Hyun SJ, Kim EK, Yoon JH, Moon HJ, Kim MJ. Adding MRI to ultrasound and ultrasound- guided fine-needle aspiration reduces the false-negative rate of axillary lymph node metastasis diagnosis in breast cancer patients.Clin Radiol. 2015 Jul;70(7):716-22. doi: 10.1016/j. crad.2015.03.004.Search in Google Scholar

16. Giuliano AE, Han SH. Local and regional control in breast cancer: role of sentinel node biopsy. Adv Surg. 2011;45:101-16.10.1016/j.yasu.2011.03.01521954681Search in Google Scholar

17. Mamounas ET. Optimal Management of the Axilla: A Look at the Evidence. Adv Surg. 2016 Sep;50(1):29-40. doi: 10.1016/j. yasu.2016.03.003.Search in Google Scholar

18. Moncayo VM, Aarsvold JN, Grant SF, Bartley SC, Alazraki NP. Status of sentinel lymph node for breast cancer.Semin Nucl Med. 2013 Jul;43(4):281-93. doi: 10.1053/j.semnuclmed. 2013.02.004.Search in Google Scholar

19. Gherghe M, Bordea C, Blidaru A. Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. J Med Life. 2015 Apr-Jun;8(2):176-80.Search in Google Scholar

20. Zervoudis S, Iatrakis G, Tomara E, Bothou A, Papadopoulos G, Tsakiris G. Main controversies in breast cancer.World J Clin Oncol. 2014 Aug 10;5(3):359-73. doi: 10.5306/wjco.v5.i3.359Search in Google Scholar

21. Guillén-Paredes MP, Carrasco-González L, Cháves-Benito A, Campillo-Soto A, Carrillo A, Aguayo-Albasini JL. One-step nucleic acid amplification (OSNA) assay for sentinel lymph node metastases as an alternative to conventional postoperative histology in breast cancer: A cost-benefit analysis.Cir Esp. 2011 Aug-Sep;89(7):456-62. doi: 10.1016/j. ciresp.2011.04.013Search in Google Scholar

22. Takamoto K, Shimazu K, Naoi Y, Shimomura A, Shimoda M, Kagara N, Kim SJ, Tamaki Y, Noguchi S. One-Step Nucleic Acid Amplification Assay for Detection of Axillary Lymph Node Metastases in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Ann Surg Oncol. 2016 Jan;23(1):78-86. doi: 10.1245/s10434-015-4693-y.Search in Google Scholar

23. Jimbo K, Kinoshita T, Suzuki J, Asaga S, Hojo T, Yoshida M, Tsuda H. Sentinel and nonsentinel lymph node assessment using a combination of one-step nucleic acid amplification and conventional histological examination. Breast. 2013 Dec;22(6):1194-9. doi: 10.1016/j. breast.2013.08.003Search in Google Scholar

24. Postacı H, Zengel B, Yararbaş U, Uslu A, Eliyatkın N, Akpınar G, Cengiz F, Durusoy R-Sentinel lymph node biopsy in breast cancer: predictors of axillary and non-sentinel lymph node involvement. Balkan Med J. 2013 Dec;30(4):415-21. doi: 10.5152/balkanmedj.2013.9591.Search in Google Scholar

25. Jiao D, Qiao J, Lu Z, Li L, Zhang H, Liu H, Cui S, Liu Z. Analysis of predictive factors affecting sentinel lymph node status in early breast cancer patients. Zhonghua Zhong Liu Za Zhi. 2014 Mar;36(3):198-201.Search in Google Scholar

26. Jaime Jans B, Nicolás Escudero M, Dahiana Pulgar B, Francisco Acevedo C, César Sánchez R, Camus AM -Clinicopathologic subtypes and compromise of lymph nodes in patients with breast cancer. Ecancermedicalscience. 2014 Jul 23;8:448. doi: 10.3332/ecancer.2014.448. eCollection 2014.Search in Google Scholar

27. Ugras S, Stempel M, Patil S, Morrow M. Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement. Ann Surg Oncol. 2014 Nov;21(12):3780-6. doi: 10.1245/s10434-014-3851-y.Search in Google Scholar

28. Gangi A, Mirocha J, Leong T, Giuliano AE. Triple-negative breast cancer is not associated with increased likelihood of nodal metastases. Ann Surg Oncol. 2014 Dec;21(13):4098-103. doi: 10.1245/s10434-014-3989-7.Search in Google Scholar

29. Pijnappel EN, Bhoo-Pathy N, Suniza J, See MH, Tan GH, Yip CH, Hartman M, Taib NA, Verkooijen HM.- Prediction of lymph node involvement in patients with breast tumors measuring 3-5 cm in a middle-income setting: the role of Cancer- Math. World J Surg. 2014 Dec;38(12):3133-7. doi: 10.1007/s00268-014-2752-3.Search in Google Scholar

30. Sawaki M, Idota A, Ichikawa M, Gondo N, Horio A, Kondo N, Hattori M, Fujita T, Yatabe Y, Iwata H. - Impact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer. Oncol Lett. 2014 Oct;8(4):1707-1712.10.3892/ol.2014.2333Search in Google Scholar

31. Brenin DR, Manasseh DM, El-Tamer M, Troxel A, Schnabel F, Ditkoff BA, Kinne D. Factors correlating with lymph node metastases in patients with T1 breast cancer.Ann Surg Oncol. 2001 Jun;8(5):432-7.10.1007/s10434-001-0432-7Search in Google Scholar

32. Chung MJ, Lee JH, Kim SH, Suh YJ, Choi HJ. Simple Prediction Model of Axillary Lymph Node Positivity After Analyzing Molecular and Clinical Factors in Early Breast Cancer. Medicine (Baltimore). 2016 May;95(20):e3689. doi: 10.1097/MD.0000000000003689.Search in Google Scholar

33. Chadha M, Chabon AB, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis. Cancer. 1994 Jan 15;73(2):350-3.10.1002/1097-0142(19940115)73:2<350::AID-CNCR2820730219>3.0.CO;2-5Search in Google Scholar

34. Tan LG, Tan YY, Heng D, Chan MY Predictors of axillary lymph node metastases in women with early breast cancer in Singapore.Singapore Med J. 2005 Dec;46(12):693-7.Search in Google Scholar

35. Gajdos C, Tartter PI, Bleiweiss IJ. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers.Ann Surg. 1999 Nov;230(5):692-610.1097/00000658-199911000-00012142092410561094Search in Google Scholar

36. Qiu PF, Liu JJ, Wang YS, Yang GR, Liu YB, Sun X, Wang CJ, Zhang ZP. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram inbreast cancer patients. Jpn J Clin Oncol. 2012 Nov;42(11):1002-710.1093/jjco/hys15023100610Search in Google Scholar

37. Ashturkar AV1, Pathak GS, Deshmukh SD, Pandave HT. Factors predicting the axillary lymph node metastasis in breast cancer: is axillary node clearance indicated in every breast cancer patient?: factors predicting the axillary lymphnode metastases in breast cancer.Indian J Surg. 2011 Oct;73(5):331-5.10.1007/s12262-011-0315-5320871623024536Search in Google Scholar

38. Wu SG, He ZY, Ren HY, Yang LC, Sun JY, Li FY, Guo L, Lin HX. Use of CEA and CA15-3 to Predict Axillary Lymph Node Metastasis in Patients with Breast Cancer. J Cancer. 2016 Jan 1;7(1):37-41. doi: 10.7150/jca.13090. eCollection 2016Search in Google Scholar

39. Tseng HS, Chen LS, Kuo SJ, Chen ST, Wang YF, Chen DR. Tumor characteristics of breast cancer in predicting axillary lymph node metastasis. Med Sci Monit. 2014 Jul 7;20:1155-61.10.12659/MSM.890491409920924998473Search in Google Scholar

40. Ko BS, Lim WS, Kim HJ, Yu JH, Lee JW, Kwan SB, Lee YM, Son BH, Gong GY, Ahn SH.-Risk factor for axillary lymph node metastases in microinvasive breast cancer.Ann Surg Oncol. 2012 Jan;19(1):212-6. 10.1245/s10434-011-1812-221633867Search in Google Scholar

41. Ngô C, Mouttet D, De Rycke Y, Reyal F, Fourchotte V, Hugonnet F, Falcou MC, Bidard FC, Vincent-Salomon A, Fourquet A, Alran S. Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma.Eur J Surg Oncol. 2012 Dec;38(12):1211-710.1016/j.ejso.2012.08.00722954526Search in Google Scholar

42. Yoo SH, Park IA, Chung YR, Kim H, Lee K, Noh DY, Im SA, Han W, Moon HG, Lee KH, Ryu HS. A histomorphologic predictive model for axillary lymph node metastasis in preoperative breastcancer core needle biopsy according to intrinsic subtypes. Hum Pathol. 2015 Feb; 46(2):246-54. doi: 10.1016/j. humpath.2014.10.017.Search in Google Scholar

43. Danko ME, Bennett KM, Zhai J, Marks JR, Olson JA Jr. Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up. J Am Coll Surg. 2010 May;210(5):797-805.e1, 805-7. doi: 10.1016/j.jamcollsurg.2010.02.045Search in Google Scholar

44. Cabioglu N, Yazici MS, Arun B, Broglio KR, Hortobagyi GN, Price JE, Sahin A. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res. 2005 Aug 15;11(16):5686-9310.1158/1078-0432.CCR-05-001416115904Search in Google Scholar

45. Capdet J, Martel P, Charitansky H, Lim YK, Ferron G, Battle L, Landier A, Mery E, Zerdoub S, Roche H, Querleu D. Factors predicting the sentinel node metastases in T1 breast cancer tumor: an analysis of 1416 cases. Eur J Surg Oncol. 2009 Dec;35(12):1245-9. doi: 10.1016/j. ejso.2009.06.002.Search in Google Scholar

46. Susini T, Nori J, Olivieri S, Molino C, Marini G, Bianchi S, Vezzosi V, Livi L, Mascalchi M, Scarselli G. Predicting the status of axillary lymph nodes in breast cancer: a multiparameter approach including axillary ultrasound scanning. Breast. 2009 Apr;18(2):103-8.10.1016/j.breast.2009.02.00119285396Search in Google Scholar

47. Wasuthit Y, Kongdan Y, Suvikapakornkul R, Lertsithichai P, Chirappapha P. Predictive factors of axillary lymph node metastasis in breast cancer.J Med Assoc Thai. 2011 Jan;94(1):65-70.Search in Google Scholar

48. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology GroupZ0011 randomized trial.Ann Surg. 2010 Sep;252(3):426-32;10.1097/SLA.0b013e3181f08f32559342120739842Search in Google Scholar

49. Meattini I, Saieva C, Bertocci S, Francolini G, Zei G, De Luca Cardillo C, Scotti V, Greto D, Bonomo P, Orzalesi L, Bianchi S, Livi L. Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node.Tumori. 2015 Jan- Feb; 101(1):78-83.10.5301/tj.500022025702658Search in Google Scholar

50. Nadeem RM, Gudur LD, Saidan ZA. An independent assessment of the 7 nomograms for predicting the probability of additional axillary nodal metastases after positive sentinel lymph node biopsy in a cohort of British patients with breastcancer.Clin Breast Cancer. 2014 Aug;14(4):272-910.1016/j.clbc.2014.02.00625037530Search in Google Scholar

51. van den Hoven I, Kuijt G, Roumen R, Voogd A, Steyerberg EW, Vergouwe Y. A head to head comparison of nine tools predicting non-sentinel lymph node status in sentinel node positive breast cancer women.J Surg Oncol. 2015 Aug;112(2):133-8.10.1002/jso.2399226258749Search in Google Scholar

52. van den Hoven I, van Klaveren D, Voogd AC, Vergouwe Y, Tjan-Heijnen V, Roumen RM. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.Clin Breast Cancer. 2016 Apr;16(2):123-30.10.1016/j.clbc.2015.09.00326602438Search in Google Scholar

53. Kuo YL, Chen WC, Yao WJ, Cheng L, Hsu HP, Lai HW, Kuo SJ, Chen DR, Chang TW. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.Int J Surg. 2013;11(7):538-4310.1016/j.ijsu.2013.05.00523707626Search in Google Scholar

54. Cordero JM, Bernet L, Cano R, Bustamante M, Vila R, Ballester B, González PJ. Study of the sentinel node in breast cancer using lymphoscintigraphy and a fast method for cytokeratin. Rev Esp Med Nucl. 2004 Jan-Feb;23(1):9-1410.1157/13056055Search in Google Scholar

55. Gur AS, Unal B, Johnson R, Ahrendt G, Bonaventura M, Gordon P, Soran A. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.J Am Coll Surg. 2009 Feb;208(2):229-3510.1016/j.jamcollsurg.2008.10.02919228534Search in Google Scholar

56. Gur AS, Unal B, Ozbek U, Ozmen V, Aydogan F, Gokgoz S, Gulluoglu BM, Aksaz E, Ozbas S, Baskan S, Koyuncu A, Soran A; Turkish Federation of Breast Disease Associations Protocol MF08-01 investigators.- Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol. 2010 Jan;36(1):30-5.10.1016/j.ejso.2009.05.00719535217Search in Google Scholar

57. Cserni G, Bori R, Maráz R, Leidenius MH, Meretoja TJ, Heikkila PS, Regitnig P, Luschin-Ebengreuth G, Zgajnar J, Perhavec A, Gazic B, Lázár G, Takács T, Vörös A, Audisio RA. Multi-institutional comparison of non-sentinel lymph node predictive tools in breast cancer patients with high predicted risk of further axillary metastasis. Pathol Oncol Res. 2013 Jan;19(1):95-10110.1007/s12253-012-9553-522798061Search in Google Scholar

58. Cserni G, Boross G, Maráz R, Leidenius MH, Meretoja TJ, Heikkila PS, Regitnig P, Luschin- Ebengreuth G, Zgajnar J, Perhavec A, Gazic B, Lázár G, Takács T, Vörös A, Audisio RA. Multicentre validation of different predictive tools of non-sentinel lymph node involvement in breast cancer.Surg Oncol. 2012 Jun;21(2):59-65.10.1016/j.suronc.2011.12.00122197294Search in Google Scholar

59. Freedman GM, Fowble BL, Li T, Hwang ES, Schechter N, Devarajan K, Anderson PR, Sigurdson ER, Goldstein LJ, Bleicher RJ. Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status. Breast J. 2014 Jul-Aug;20(4):358-6310.1111/tbj.12276447243724861613Search in Google Scholar

60. Gülben K, Berberoğlu U, Aydoğan O, Kınaş V. Subtype is a predictive factor of nonsentinel lymph node involvement in sentinel node-positive breast cancer patients.J Breast Cancer. 2014 Dec;17(4):370-5.10.4048/jbc.2014.17.4.370427805725548586Search in Google Scholar

61. Cecilia Williams and Chin-Yo Lin Oestrogen receptors in breast cancer: basic mechanisms and clinical implications; Ecancermedicalscience. 2013; 7: 370.Search in Google Scholar

62. Carolina Gutierrez, M.D. and Rachel Schiff, Ph.D. HER 2: Biology, Detection, and Clinical Implications; Arch Pathol Lab Med. 2011 Jan; 135(1): 55-62.10.5858/2010-0454-RAR.1324241821204711Search in Google Scholar

63. P J van Diest, E van der Wall, and J P A Baak. Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol. 2004 Jul; 57(7): 675-681. 10.1136/jcp.2003.010777177035115220356Search in Google Scholar